PORTLAND, Oregon, April 7, 2020 /PRNewswire/ -- Allied Market Research recently published a report, titled, "Inhalation Anesthesia Market by Product (Sevoflurane, Desflurane, Isoflurane, and Nitrous Oxide), Application (Induction and Maintenance), and End-User (Hospitals and Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2019–2026".According to the report, the global inhalation anesthesia industry garnered $1.13 billion in 2018, and is anticipated to reach $1.54 billion by 2026, growing at a CAGR of 4.2% from 2019 to 2026.
Drivers, restraints, and opportunities
Rise in number of surgeries and increase in severe road accidents have boosted the growth of the global inhalation anesthesia market. However, stringent regulatory scenario hampers the market growth. On the contrary, growth opportunities in the emerging economies would propel the market growth in the coming years.
Based on product, the sevoflurane segment held the largest share in 2018, accounting for nearly three-fifths of the global inhalation anesthesia market, owing tothe fact that induction of anesthesia with sevoflurane is favorable in neonates compared to isoflurane and desflurane, as it lacks airway irritation.However, the desflurane segment is expected to reach the fastest CAGR of 5.1% during the forecast period. Desflurane is widely used in ambulatory anesthesia as it possesses the properties of an ideal agent that has lower blood gas solubility, resulting in rapid induction and emergence from anesthesia. This property of desflurane is anticipated to contribute to its market growth in the future
Maintenance segment to manifest fastest growth
The maintenance segment is projected to portray the highest CAGR of 4.3% during the study period. Moreover, the segment held the largest share in 2018, accounting for more than four-fifths of the global inhalation anesthesia market. This is due to the fact that inhalational anesthetics are widely and majorly used for the maintenance segment of general anesthesia as well as sedation. The research also analyzes the induction segment.
North America held the lion's share
The global inhalation anesthesia market across North America held the largest share in 2018, contributing to nearly half of the total revenue, due torise in government funds for R&D of novel inhalation anesthesia as well as surge in incidences of cancer.However, the market across Asia-Pacific is expected to manifest the highest CAGR of 6.0% during the forecast period, owing to increase in disorders such as cancer and respiratory that often need surgery.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.